← All publishers
98 skillsAvg Trust: 67
98 skills
ksb-d01-k0001-thalidomide-legacy
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0002-regulatory-development
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d01-k0003-global-harmonization
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0004-technology-evolution
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0005-population-health-impact
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d01-k0007-pandemic-preparedness
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0008-global-health-perspective
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0009-fda-guidance
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d01-k0010-ema-framework
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0012-regional-variations
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d01-k0013-core-ethical-principles
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0014-informed-consent
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d01-k0015-transparency-standards
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0016-professional-responsibility
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0017-aiml-terminology
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0018-application-areas
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0019-validation-requirements
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d01-k0020-ethical-ai
Scannednexvigilant/.true
Trust: 40nexvigilant/.truev1.0.0today
ksb-d02-k0001-type-a-reactions
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0002-type-b-reactions
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d02-k0004-type-d-reactions
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0005-type-e-reactions
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d02-k0006-type-f-reactions
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d02-k0007-pharmacokinetic-factors
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d02-k0008-pharmacodynamic-interactions
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0009-drug-drug-interactions
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today
ksb-d02-k0010-drug-disease-interactions
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0011-pharmacogenetic-influences
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0012-causality-assessment-methods
Scannednexvigilant/.true
Trust: 69nexvigilant/.truev1.0.0today
ksb-d02-k0013-temporal-relationship-analysis
Scannednexvigilant/.true
Trust: 67nexvigilant/.truev1.0.0today